Carrie Mason with Lonza Integrated Biologics discusses how PAT and AI are transforming biomanufacturing with predictive, integrated bioprocessing that speeds complex biologics through to clinic.
Carrie Mason
Advertisement
Carrie Mason is head of Process Analytical Technologies (PAT) Center of Excellence at. Lonza Integrated Biologics.
Articles by Carrie Mason
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Clears In-Vivo Gene Editing Therapy PBGENE-DMD for Duchenne Trial
2
The Clinical Execution Gap: Why Great Science Often Fails at the Trial Stage
3
VectorY Doses First Patient in TDP-43–Targeting ALS Trial
4
Preclinical Study Finds Subcutaneous Nanotrastuzumab Comparable to Herceptin HYLECTA in Minipig Model
5